/Investor DB

VantagePoint Capital Partners — 2014 Investments

4 investments dated 2014 · listed companies and verified rows first · show all

Phreesiaphreesia.comin𝕏NYSE: PHROct 2014

Phreesia provides a patient intake and engagement platform with automated tools for registration, insurance verification, appointment access, and payments used by healthcare organizations.

Digital HealthHealthtechSaaSNew York, US

Chaim Indig(Executive Officer, Director)Evan Roberts(Executive Officer)inCharles Kallenbach(Executive Officer)inThomas Altier(Executive Officer)inBalaji Gandhi(Chief Financial Officer)inDavid Linetsky(President, Network Solutions)in

Co-investorsAscension VenturesBlue Venture FundsEscalate Capital PartnersHLM Investment PartnersLLRLRVHealth

Pica8pica8.orgSep 2014

Pica8 develops PICOS, a Linux-based open network operating system, and the AmpCon controller for white box enterprise networks.

Palo Alto, US

Chunyi (James) Liao(Executive Officer, Director)

BoardTerry Chen(Director)inChen-Wen Tarn(Director)Mike Splinter(Director)

Co-investorsMitsui Global InvestmentWI Harper Group

VeriSiliconverisilicon.comin𝕏Jun 2014

Verisilicon is a Chinese semiconductor IP and chip design solutions company that provides Silicon Platform as a Service (SiPaaS), offering customized chip design platforms with proprietary IP cores including GPU, NPU, VPU, DSP, ISP, and display processing IPs.

AI & Machine LearningDeep TechHardwareSemiconductorsShanghai, CN

Wayne Wei-Ming Dai(Executive Officer, Director)Shannon Gao(Executive Officer)

BoardSoo Boon Koh(Director)inDatong Chen(Director)Ben Yu(Director)Yajun Li(Director)

Co-investorsCelesta CapitaliGlobe PartnersSierra VenturesWestSummit CapitalWI Harper Group

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Tendril Networks

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.